Phaseline

Companies › Nanjing Leads Biolabs

Nanjing Leads Biolabs: clinical trials, targets and expected readouts

3 active drug programs in 12 registered trials: 8 Phase 1, 4 Phase 2; Oncology, Immunology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
LBL-024–Phase 2Advanced Solid Tumour; Advanced Solid Tumor; Advanced Neuroendocrine Carcinoma; Advanced Melanoma …Dec 2026
LBL-034–Phase 1Relapsed/Refractory Multiple MyelomaMay 2027
LBL-047–Phase 1Systemic Lupus ErythematosusDec 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05170958LBL-024Phase 1Advanced Solid TumorOncologyDec 2026
NCT06783647LBL-024Phase 2Advanced Solid TumourOncologyDec 2026
NCT06157827LBL-024Phase 1Advanced Neuroendocrine CarcinomaOncologyDec 2026
NCT06049290LBL-034Phase 1Relapsed/Refractory Multiple MyelomaOncologyMay 2027
NCT07099430LBL-024Phase 1Advanced MelanomaOncologyOct 2027
NCT07323173LBL-047Phase 1Systemic Lupus ErythematosusImmunologyDec 2027
NCT07042802LBL-024Phase 1Ovarian CancerOncologyDec 2027
NCT07111546LBL-024Phase 2Advanced Solid TumourOncologyDec 2027
NCT07281976LBL-024Phase 1Triple Negative Breast CancerOncologyDec 2027
NCT07390383LBL-024Phase 2Advanced Solid TumourOncologyMay 2028
NCT07331155LBL-024Phase 2Advanced Solid TumourOncologyDec 2028
NCT07791758LBL-024Phase 1Metastatic Colorectal CarcinomaOncologySep 2030

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Jacobio Pharmaceuticals HighField Biopharmaceuticals HC Biopharma Nanjing IASO Biotechnology Molecure

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.